1. Home
  2. PECO vs IMVT Comparison

PECO vs IMVT Comparison

Compare PECO & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phillips Edison & Company Inc.

PECO

Phillips Edison & Company Inc.

HOLD

Current Price

$39.28

Market Cap

5.0B

Sector

Real Estate

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$27.64

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PECO
IMVT
Founded
1991
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.8B
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
PECO
IMVT
Price
$39.28
$27.64
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$39.71
$33.00
AVG Volume (30 Days)
798.8K
1.4M
Earning Date
04-23-2026
05-28-2026
Dividend Yield
3.26%
N/A
EPS Growth
74.51
N/A
EPS
0.24
N/A
Revenue
$726,594,000.00
N/A
Revenue This Year
$5.82
N/A
Revenue Next Year
$3.81
N/A
P/E Ratio
$165.63
N/A
Revenue Growth
9.86
N/A
52 Week Low
$32.84
$13.79
52 Week High
$40.71
$30.16

Technical Indicators

Market Signals
Indicator
PECO
IMVT
Relative Strength Index (RSI) 49.56 49.72
Support Level $38.90 $24.97
Resistance Level $39.86 $27.71
Average True Range (ATR) 0.59 1.51
MACD -0.12 -0.05
Stochastic Oscillator 20.72 39.30

Price Performance

Historical Comparison
PECO
IMVT

About PECO Phillips Edison & Company Inc.

Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interest, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on a market of expertise designed to optimize property value and consistently deliver a great shopping experience.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: